Brief: Active Biotech Enters Into Clinical Trial Collaboration Agreement
31/07/2023 07:54
July 31 (Reuters) - Active Biotech AB publ ACTI.ST :
* ACTIVE BIOTECH ENTERS INTO CLINICAL TRIAL COLLABORATION
AGREEMENT FOR A CLINICAL STUDY WITH TASQUINIMOD IN MYELOFIBROSIS
* PLANNED STUDY WILL INVESTIGATE TASQUINIMOD GIVEN AS
MONOTHERAPY
TO PATIENTS WITH MYELOFIBROSIS
Source text for Eikon: ID:nMFN5mJtBl
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))